Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation

Detalles Bibliográficos
Autores principales: Schönefeldt, C, Sockel, K, Wehner, R, Sopper, S, Wolf, D, Wermke, M, Thiede, C, Oelschlägel, U, Ehninger, G, Bornhäuser, M, Platzbecker, U, Schmitz, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763388/
https://www.ncbi.nlm.nih.gov/pubmed/23995045
http://dx.doi.org/10.1038/bcj.2013.35
_version_ 1782283005380788224
author Schönefeldt, C
Sockel, K
Wehner, R
Sopper, S
Wolf, D
Wermke, M
Thiede, C
Oelschlägel, U
Ehninger, G
Bornhäuser, M
Platzbecker, U
Schmitz, M
author_facet Schönefeldt, C
Sockel, K
Wehner, R
Sopper, S
Wolf, D
Wermke, M
Thiede, C
Oelschlägel, U
Ehninger, G
Bornhäuser, M
Platzbecker, U
Schmitz, M
author_sort Schönefeldt, C
collection PubMed
description
format Online
Article
Text
id pubmed-3763388
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37633882013-09-11 Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation Schönefeldt, C Sockel, K Wehner, R Sopper, S Wolf, D Wermke, M Thiede, C Oelschlägel, U Ehninger, G Bornhäuser, M Platzbecker, U Schmitz, M Blood Cancer J Letter to the Editor Nature Publishing Group 2013-08 2013-08-30 /pmc/articles/PMC3763388/ /pubmed/23995045 http://dx.doi.org/10.1038/bcj.2013.35 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Letter to the Editor
Schönefeldt, C
Sockel, K
Wehner, R
Sopper, S
Wolf, D
Wermke, M
Thiede, C
Oelschlägel, U
Ehninger, G
Bornhäuser, M
Platzbecker, U
Schmitz, M
Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title_full Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title_fullStr Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title_full_unstemmed Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title_short Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
title_sort azacytidine impairs nk cell activity in aml and mds patients undergoing mrd-based pre-emptive treatment after allogeneic stem cell transplantation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763388/
https://www.ncbi.nlm.nih.gov/pubmed/23995045
http://dx.doi.org/10.1038/bcj.2013.35
work_keys_str_mv AT schonefeldtc azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT sockelk azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT wehnerr azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT soppers azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT wolfd azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT wermkem azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT thiedec azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT oelschlagelu azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT ehningerg azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT bornhauserm azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT platzbeckeru azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation
AT schmitzm azacytidineimpairsnkcellactivityinamlandmdspatientsundergoingmrdbasedpreemptivetreatmentafterallogeneicstemcelltransplantation

Ejemplares similares